NIKKEI 225
38,141.53 +179.73 (+0.47%) HANG SENG
16,426.71 +174.87 (+1.08%) CRUDE OIL
82.84 +0.15 (+0.18%) GOLD FUTURES
2,390.80 +2.40 (+0.10%) DOW
37,753.31 -45.66 (-0.12%) Bitcoin GBP
48,959.11 -2,305.71 (-4.50%)
CI Jan 2025 290.000 call
| Previous close | 69.10 |
| Open | 69.10 |
| Bid | 77.60 |
| Ask | 80.50 |
| Strike | 290.00 |
| Expiry date | 2025-01-17 |
| Day's range | 69.10 - 69.10 |
| Contract range | N/A |
| Volume | |
| Open interest | 447 |
ZacksWill Cigna (CI) Beat Estimates Again in Its Next Earnings Report?
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Reuters
EXPLAINER-Why are US pharmacy benefit managers under fire?
Pharmacy benefit managers (PBMs) are in the crosshairs of Republicans and Democrats in Congress but have so far dodged any new litigation or reforms that had been targeted for inclusion in last month's U.S. government budget deal. Many lawmakers, drugmakers and government officials have pointed a finger at these industry middle men, suggesting they play a critical role in high prescription drug costs in the United States. The following is what you need to know about PBMs.
Insider Monkey14 Best 52-Week High Stocks To Invest In Now
This article delves into the examination of the 14 best 52-week high stocks to buy now. To explore more such companies that meet comparable criteria, go directly to 5 Best 52-Week High Stocks To Buy Now. The outlook for 2024 is positive for the economy and the stock market. Market conditions improved significantly in Q4 […]
